BioCentury
ARTICLE | Company News

TapImmune, Mayo Clinic deal

June 7, 2010 7:00 AM UTC

The clinic granted TapImmune an exclusive option to license its breast cancer vaccine technology after Phase I testing. The clinic plans to file an IND in the next 6-8 months for a Phase I trial of t...